BioCentury
ARTICLE | Product Development

Genomics plc puts polygenic risk scores to the test with NHS pilot 

March 22, 2021 10:51 PM UTC

On the heels of a $30 million venture round and a publication describing its risk prediction tool for coronary artery disease (CAD), Genomics plc is launching a pilot with NHS to test its polygenic risk score-based technology.

The trial will take place in northeast England and will test the CAD prediction tool, which also incorporates factors such as age, sex and BMI, in about 1,000 individuals. ...

BCIQ Company Profiles

Genomics plc

NHS England